Blood -- The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

Blood, Vol. 112, Issue 8, 3126-3129, October 15, 2008

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
Blood O'Shea et al. 112: 3126

Supplemental materials for: O’Shea et al

Files in this Data Supplement:

Table S1. Association of TP53 mutation with clinical characteristics and disease course (PDF, 38.6 KB)